Pharmacy

Your Article Summary

See Latest Articles

New investigational combination telmisartan and amlodipine shows effective and well-tolerated 24-hour blood pressure control in hypertensive patients at risk of cardiovascular events
Boehringer Ingelheim, 06/15/09

Data presented at the 19th Scientific Meeting of the European Society of Hypertension, Milan, Italy has demonstrated that treatment with an investigational combination of telmisartan and amlodipine shows substantial and sustained 24-hour blood pressure lowering and is well-tolerated in a range of patients with hypertension at risk of cardiovascular events. This includes patients with Type 2 diabetes, obese patients, the elderly, black patients and those not controlled by amlodipine alone

Today in Cardiac/Hypertension...keeping you current

Receive free subspecialty "5-minute updates" via email

Recent Caffeine Ingestion Reduces Adenosine Efficacy in the Treatment of Paroxysmal Supraventricular Tachycardia
Academic Emergency Medicine, 12/11/09

Year Two Assessment of Fenofibric Acid and Moderate-Dose Statin Combination: A Phase 3, Open-Label, Extension Study
Clinical Drug Investigation, 12/11/09

Inotrope and vasopressor use in the emergency department
Emergency Medicine Australasia, 12/10/09

 See all of Cardiac/Hypertension

Today in Drug Interactions...keeping you current

Receive free subspecialty "5-minute updates" via email

A comparison of the acid-inhibitory effects of esomeprazole and pantoprazole in relation to pharmacokinetics and CYP2C19 polymorphism
Alimentary Pharmacology and Therapeutics, 12/10/09

Combination of intensive cognitive rehabilitation and donepezil therapy in Alzheimer's disease (AD)
Archives of Gerontology and Geriatrics, 12/09/09

Subcutaneous Sumatriptan Pharmacokinetics: Delimiting the Monoamine Oxidase Inhibitor Effect
Headache: The Journal of Head and Face Pain, 12/08/09

 See all of Drug Interactions